NDC 70518-4516-00 - Lisinopril and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4516
- Requested NDC
- 70518-4516-00
- Package NDCs from labels
- 70518-4516-0, 70518-4516-1, 70518-4516-00
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, USP for oral use Rx Only | REMEDYREPACK INC. | 2026-09-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4516-0 | Lisinopril and Hydrochlorothiazide | 30 in 1 BLISTER PACK | TABLET | 30 | 2 | |
| 70518-4516-1 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 2db1a899-f115-4da5-89fe-6e5b41086f6c | 2026-09-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | 5ba10848-9a4c-1a28-e063-6394a90ab047 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 5ba2325f-5fc1-f6f0-e063-6294a90aefc6 | 2026-09-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Metoprolol Tartrate and Hydrochlorothiazide | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | b6cf0f43-8dc3-4535-b651-daf1f9e0336c | 2026-09-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| lisinopril | LISINOPRIL | REMEDYREPACK INC. | c57e8bc8-ff50-431e-9c1a-384503584d02 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | REMEDYREPACK INC. | d383e0e5-4e00-44cc-9d6f-86e76f4e79e3 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | ANDA076230 70518-4516-1 70518-4516-0 70518-4516 70518451600 197885 5b8875a8-2bba-42fe-e063-6394a90ab3dc d383e0e5-4e00-44cc-9d6f-86e76f4e79e3 E7199S1YWR 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 206cd386-cf38-4e0f-80ec-685aea41b048 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 1fad059f-f030-4dd8-b02a-bf3e775d37d2 | 2026-09-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan medoxomil and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 20a76be4-05c1-4df3-96ae-cb9f7f3dfe09 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | PD-Rx Pharmaceuticals, Inc. | 9470b102-3c81-469a-a4c5-6816d9d39b07 | 2026-09-14 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Spironolactone and hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd. | 9c6c8815-50d8-4a3c-b348-98d5084c1408 | 2026-09-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | 8a1de4e2-3aca-a4d3-e053-2995a90a1a41 | 2026-09-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 71691ccf-0ed9-4a14-8da6-7ab9b9698f52 | 2026-09-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Par Health USA, LLC | 268d12e8-1cfc-4086-b613-8fd94f2d7c4e | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | Cardinal Health 107, LLC | 764d51bf-731f-4a37-8e30-e79328cf5a12 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | GLENMARK PHARMACEUTICALS INC., USA | ab73a6d8-2e33-4fdc-a896-6c68ab772da6 | 2026-09-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 5ee165a3-39a4-4d12-aff2-a6fb3309ce39 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | AvKARE | 1b303136-dccd-178b-e063-6394a90a35f8 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 7dc3414b-dcb5-4b11-bca7-c0fa3f474aea | 2026-09-03 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Edenbridge Pharmaceuticals LLC. | 295532b5-65c8-40c3-8d27-cfd334d12802 | 2026-08-28 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.